Us Bancorp »

Dianthus Therapeutics shares owned by Us Bancorp

Quarter-by-quarter ownership of Dianthus Therapeutics (DNTH) shares owned by Us Bancorp from 13F filings

Historical chart of Us Bancorp investment in Dianthus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dianthus Therapeutics held by Us Bancorp consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dianthus Therapeutics by Us Bancorp

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.8k 65 27.38

More positions owned by Us Bancorp

Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core Us Aggbd Et (AGG)
Apple (AAPL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core Msci Eafe (IEFA)
Microsoft Corporation (MSFT)
Eli Lilly & Co. (LLY)
Ishares Tr Rus Mid Cap Etf (IWR)
Ishares Core Msci Emkt (IEMG)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
NVIDIA Corporation (NVDA)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)

View all positions for Us Bancorp

Top funds holding Dianthus Therapeutics

Bain Capital Life Sciences Investors
Avidity Partners Management
Fairmount Funds Management
RA Capital Management
Octagon Capital Advisors
VR Adviser
BlackRock
BlackRock
Vanguard Group
5AM Venture Management
Henderson Group
Braidwell
Geode Capital Management
Point72 Asset Management
State Street Corporation

View all funds holding Dianthus Therapeutics